Intercept Pharmaceuticals
ICPT
$19.00
Share price
0.00%
Change (1 day)
-7.90%
Change (1 year)
Categories
Intercept Pharmaceuticals (ICPT) - P/B ratio
P/B ratio as of June 2024 : 11.1
According to Intercept Pharmaceuticals
's latest financial reports the company has a price-to-book ratio of 11.1.
The price-to-book ratio is a way to measure how much the stock market thinks a company is worth compared to how much the company says its assets are worth on paper.
Intercept Pharmaceuticals - P/B ratio (from 2012 to 2022)
P/B ratio by year
| Year | P/B ratio | Change |
|---|---|---|
| 2022-12-31 | 5.50 | -310.38% |
| 2021-12-31 | -2.62 | -46.43% |
| 2020-12-31 | -4.88 | -106.18% |
| 2019-12-31 | 79.0 | -49.53% |
| 2018-12-31 | 156 | 74.81% |
| 2017-12-31 | 89.5 | 945.63% |
| 2016-12-31 | 8.56 | 41.48% |
| 2015-12-31 | 6.05 | -58.19% |
| 2014-12-31 | 14.5 | -9.94% |
| 2013-12-31 | 16.1 | 87.13% |
| 2012-12-31 | 8.59 | |
| 2011-12-31 | N/A |
P/B ratio for similar companies or competitors
| Company | P/B ratio | differencediff. | Country |
|---|---|---|---|
 Eli Lilly LLY | 66.7 | 502.65% | 🇺🇸 USA |
 Gilead Sciences GILD | 4.97 | -55.08% | 🇺🇸 USA |
 Bristol-Myers Squibb BMY | 5.17 | -53.28% | 🇺🇸 USA |
 MediciNova MNOV | 1.16 | -89.48% | 🇺🇸 USA |